Home / Journal / The True Annual Cost of Tirzepatide: Commitment Math Explained
pricing

The True Annual Cost of Tirzepatide: Commitment Math Explained

By Kim Callender, NP, FNP-BC · Reviewed by Kim Callender, NP, FNP-BC · Published July 15, 2026 · 1,200+ words
Relationship disclosure: GLP-1 Price Index and its publisher, US Peptides Partners LLC, have no ownership, affiliate, referral, advertising, management, reviewer, or other material financial relationship with the providers named here. All are evaluated using the same documented methodology.
Quick answer

A 12-month tirzepatide prepay lowers the monthly rate but locks you in; month-to-month costs more but lets you stop. The right choice depends on tolerability certainty and cancellation exposure. A twelve-month prepay lowers the monthly rate but exposes you to cancellation risk if you stop early, so weigh the discount against the lock-in and confirm refund terms before committing to a year.

Key takeaways

How commitment tiers work

Nearly every tirzepatide program lowers the monthly rate as the commitment lengthens. A 12-month prepay might drop the rate by $50 or more per month versus month-to-month. The discount is real, but so is the lock-in: you are prepaying for a year of a compounded, non-FDA-approved medication.

The saving from a longer commitment is only worth it if you are confident you will stay on the medication. If a side effect forces you off in month two, the remaining ten months are often non-refundable.

Annual cost by commitment (USD)12-month$17886-month$2148Month-to-month$2388

The annual math

Consider a program at $199 month-to-month versus $149 on a 12-month prepay. Month-to-month for a year is $2,388; the prepay is $1,788 — a $600 saving. But the prepay is paid upfront and rarely refundable. If you stop after three months, you have paid $1,788 for three months of use, an effective $596 per month.

This is the trap of commitment pricing: the advertised low rate assumes you complete the full term. Model both the best case (you finish) and the worst case (you stop early) before committing.

Tirzepatide commitment cost comparison (illustrative)
PlanMonthlyAnnualRefundable?
Month-to-month$199$2,388Stop anytime
6-month$179$2,148 (prepaid)Usually no
12-month$149$1,788 (prepaid)Usually no

Cancellation exposure

Prepaid and committed plans are subject to the governing agreement and typically require written notice, often 30 days, during which billing may continue. Medication already dispensed generally cannot be returned or refunded. This means your true exposure on a committed plan is the full prepaid amount plus any notice-period charges.

Read the cancellation terms before enrolling, not after. A program that makes cancellation easy and refunds undelivered months is lower-risk than one that locks the full year regardless of whether you continue.

Worst-case: stopping after 3 months
PlanPaidMonths usedEffective/mo
Month-to-month$5973$199
12-month prepay$1,7883$596

The defensible strategy

For a first-time tirzepatide patient, the defensible approach is to start month-to-month or on the shortest available tier, confirm tolerability and supply reliability, and only then convert to a longer commitment. The extra cost of month-to-month for the first few months is cheap insurance against being locked into a year of a medication you cannot tolerate.

The savings from a 12-month prepay are not worth carrying if a side effect ends treatment in month two with no refund. Weigh the per-month discount against the cost of being wrong about a year-long commitment.

Frequently asked questions

Is a 12-month tirzepatide plan worth it?

Only if you are confident you will complete it. The discount is real, but prepaid plans are usually non-refundable, so stopping early can cost far more per month than month-to-month.

Can I get a refund if I stop?

Usually not on medication already dispensed. Committed plans typically require written notice and may bill through the notice period. Read the terms first.

What is the safest approach?

Start month-to-month or short-term, confirm you tolerate the medication, then commit to a longer plan for the discount.

Sources

  1. FDA — human drug compounding and GLP-1 status.
  2. Provider plan terms captured July 2026.
  3. Evidence ledger: evidence-ledger.csv.